Estrogen receptor alpha in human breast cancer : Occurrence and significanceALI, Simak; COOMBES, R. Charles.Journal of mammary gland biology and neoplasia. 2000, Vol 5, Num 3, pp 271-281, issn 1083-3021Article

The efficacy of percutaneous vertebroplasty for vertebral metastases associated with solid malignanciesLEE, Belinda; FRANKLIN, Ingrid; LEWIS, Jacqueline S et al.European journal of cancer (1990). 2009, Vol 45, Num 9, pp 1597-1602, issn 0959-8049, 6 p.Article

Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer : Correlation with doses of epirubicin and cyclophosphamidePRAGA, Claudio; BERGH, Jonas; KERBRAT, Pierre et al.Journal of clinical oncology. 2005, Vol 23, Num 18, pp 4179-4191, issn 0732-183X, 13 p.Article

Voltage-gated sodium channel expression and potentiation of human breast cancer metastasisFRASER, Scott P; DISS, James K. J; BRACKENBURY, William J et al.Clinical cancer research. 2005, Vol 11, Num 15, pp 5381-5389, issn 1078-0432, 9 p.Article

Histone deacetylase inhibitor trichostatin A represses Estrogen receptor α-dependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell linesALAO, John Patrick; LAM, Eric W.-F; ALI, Simak et al.Clinical cancer research. 2004, Vol 10, Num 23, pp 8094-8104, issn 1078-0432, 11 p.Article

Expression of estrogen receptor β isoforms in normal breast epithelial cells and breast cancer: regulation by methylationCHUNYAN ZHAO; LAM, Eric W-F; SUNTERS, Andrew et al.Oncogene (Basingstoke). 2003, Vol 22, Num 48, pp 7600-7606, issn 0950-9232, 7 p.Article

Analysis of estrogen-responsive finger protein expression in benign and malignant human breastTHOMSON, Simon D; ALI, Simak; PICKLES, Laura et al.International journal of cancer. 2001, Vol 91, Num 2, pp 152-158, issn 0020-7136Article

Biological and clinical implications of nicastrin expression in invasive breast cancerFILIPOVIC, Aleksandra; GRONAU, Julian Hendrik; COOMBES, R. Charles et al.Breast cancer research and treatment. 2011, Vol 125, Num 1, pp 43-53, issn 0167-6806, 11 p.Article

Phosphorylation of estrogen receptor-α at ser¹⁶⁷ is indicative of longer disease-free and overall survival in breast cancer patientsJIE JIANG; SARWAR, Naveed; PESTON, David et al.Clinical cancer research. 2007, Vol 13, Num 19, pp 5769-5776, issn 1078-0432, 8 p.Article

A phase I study of oncovex^gm-csf, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factorHU, Jennifer C. C; COFFIN, Robert S; MEDLEY, Louise C et al.Clinical cancer research. 2006, Vol 12, Num 22, pp 6737-6747, issn 1078-0432, 11 p.Article

Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: Results at 4 yearsSLADE, Martin J; SINGH, Anjana; CROSS, Nicholas C. P et al.International journal of cancer. 2005, Vol 114, Num 1, pp 94-100, issn 0020-7136, 7 p.Article

Quantification of cellular proliferation in tumor and normal tissues of patients with breast cancer by [¹⁸F]fluorothymidine -positron emission tomography imaging : Evaluation of analytical methodsKENNY, Laura M; VIGUSHIN, David M; AL-NAHHAS, Adil et al.Cancer research (Baltimore). 2005, Vol 65, Num 21, pp 10104-10112, issn 0008-5472, 9 p.Article

Ghrelin increases energy intake in cancer patients with impaired appetite: Acute, randomized, placebo-controlled trialNEARY, Nicola M; SMALL, Caroline J; WREN, Alison M et al.The Journal of clinical endocrinology and metabolism. 2004, Vol 89, Num 6, pp 2832-2836, issn 0021-972X, 5 p.Article

The expression of ERβcx in human breast cancer and the relationship to endocrine therapy and survivalPALMIERI, Carlo; LAM, Eric W.-F; COOMBES, R. Charles et al.Clinical cancer research. 2004, Vol 10, Num 7, pp 2421-2428, issn 1078-0432, 8 p.Article

Phosphorylation of human estrogen receptor α at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antiseraDONGSHENG CHEN; WASHBROOK, Elinor; COOMBES, R. Charles et al.Oncogene (Basingstoke). 2002, Vol 21, Num 32, pp 4921-4931, issn 0950-9232Article

A phase I dose escalation study to determine the optimal biological dose of irosustat, an oral steroid sulfatase inhibitor, in postmenopausal women with estrogen receptor-positive breast cancerCOOMBES, R. Charles; CARDOSO, Fatima; ISAMBERT, Nicolas et al.Breast cancer research and treatment. 2013, Vol 140, Num 1, pp 73-82, issn 0167-6806, 10 p.Article

The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cellsTHIRUCHELVAM, Paul T. R; LAI, Chun-Fui; SPIVEY, Alan C et al.Breast cancer research and treatment. 2011, Vol 127, Num 2, pp 385-396, issn 0167-6806, 12 p.Article

Longer-Term Assessment of Trastuzumab-Related Cardiac Adverse Events in the Herceptin Adjuvant (HERA) TrialPROCTER, Marion; SUTER, Thomas M; COOMBES, R. Charles et al.Journal of clinical oncology. 2010, Vol 28, Num 21, pp 3422-3428, issn 0732-183X, 7 p.Article

Reversal of skeletal effects of endocrine treatments in the Intergroup Exemestane StudyCOLEMAN, Robert E; BANKS, Linda M; GIRGIS, Samia I et al.Breast cancer research and treatment. 2010, Vol 124, Num 1, pp 153-161, issn 0167-6806, 9 p.Article

Peritoneal disease in breast cancer: A specific entity with an extremely poor prognosisTUTHILL, Mark; PELL, Robert; GUILIANI, Rosa et al.European journal of cancer (1990). 2009, Vol 45, Num 12, pp 2146-2149, issn 0959-8049, 4 p.Article

A phase II trial of docetaxel (Taxotere®) as second-line chemotherapy in patients with metastatic breast cancerBAUR, Martina; VAN OOSTEROM, Allan T; DIERAS, Veronique et al.Journal of cancer research and clinical oncology. 2008, Vol 134, Num 2, pp 125-135, issn 0171-5216, 11 p.Article

Paclitaxel-lnduced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-Jun NH₂-terminal kinase and AktSUNTERS, Andrew; MADUREIRA, Patricia A; POMERANZ, Karen M et al.Cancer research (Baltimore). 2006, Vol 66, Num 1, pp 212-220, issn 0008-5472, 9 p.Article

Quality of life in the intergroup exemestane study : A randomized trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in postmenopausal women with primary breast cancerFALLOWFIELD, Lesley J. J; BLISS, Judith M; PORTER, Lucy S et al.Journal of clinical oncology. 2006, Vol 24, Num 6, pp 910-917, issn 0732-183X, 8 p.Article

A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancerCOOMBES, R. Charles; HALL, Emma; COATES, Alan S et al.The New England journal of medicine. 2004, Vol 350, Num 11, pp 1081-1092, issn 0028-4793, 12 p.Article

Stereodefined and polyunsaturated inhibitors of histone deacetylase based on (2E, 4E)-5-arylpenta-2,4-dienoic acid hydroxyamidesMARSON, Charles M; SERRADJI, Nawal; RIOJA, Alphonso S et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 10, pp 2477-2481, issn 0960-894X, 5 p.Article